Skip to main content
Journal ArticleOPEN ACCESS

SARS-CoV-2 Variants and Vaccines

  • Krause P
  • Fleming T
  • Longini I
  • et al.
New England Journal of Medicine (2021) 385(2) 179-186
DOI: 10.1056/nejmsr2105280
N/ACitations
Citations of this article
254Readers
Mendeley users who have this article in their library.

Abstract

Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based.

Cite

CITATION STYLE

APA

Krause, P. R., Fleming, T. R., Longini, I. M., Peto, R., Briand, S., Heymann, D. L., … Henao-Restrepo, A.-M. (2021). SARS-CoV-2 Variants and Vaccines. New England Journal of Medicine, 385(2), 179–186. https://doi.org/10.1056/nejmsr2105280

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free